weight loss

Hims Hers branded GLP-1
Health Tech

Hims & Hers swings to a loss in Q1 amid shift in GLP-1 strategy

Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business away from compounded weight loss drugs.
Heather Landi May 12, 2026 4:00pm
A medical bill next to a pen and cellphone

Employers say increased GLP-1 coverage drives up costs: survey

May 6, 2026 4:00pm
Ozempic Wegovy

Him & Hers now offers all FDA-approved GLP-1s

Apr 23, 2026 10:43am
Eli Lilly Lilly

Eli Lilly’s GLP-1 pill rolls out via US telehealth providers

Apr 9, 2026 11:45am
Alloy Health products

Menopause care provider Alloy Health expands weight care program

Apr 7, 2026 11:33am
Wegovy

Novo Nordisk rolls out discounted subscription plan for Wegovy

Apr 2, 2026 4:30pm